Although liraglutide is the most studied GLP-1 agonist in psychiatric patients and is available in a generic form, it requires daily dosing and is less effective than the branded, once-weekly GLP-1 agonists semaglutide and tirzepatide.
Understanding how Ozempic influences your digestive system, what to expect, and when to seek medical advice can help you manage treatment effectively and maintain quality of life whilst achieving glycaemic control
Tirzepatide takes about a month to build up in your system, and people may not reach their full maintenance dose until around week 21
Individuals with a history of pancreatitis should avoid using Tirzepatide
Clinical trial data for semaglutide points to average losses of around 15% of body weight over 68 weeks when combined with diet and lifestyle changes
Six in One Comprehensive Support: Combines six beneficial components in one convenient formula to provide comprehensive nutritional supplementation